Shin-Etsu Chemical (4063) Q3 2025 earnings summary

Executive summary

• Net sales for April–December 2024 rose 5.8% year-over-year to ¥1,929.7 billion, with operating income up 4.5% to ¥584.4 billion and net income attributable to owners of parent up 6.4% to ¥432.5 billion.

• Growth achieved despite global economic headwinds, inflation, and geopolitical risks; company focused on product development and capital investment for long-term growth.

• Comprehensive income was ¥478.9 billion, down from ¥739.9 billion the previous year, mainly due to lower foreign currency translation gains.

Financial highlights

• Gross profit increased to ¥759.3 billion from ¥714.6 billion year-over-year; operating margin remained strong.

• Total assets reached ¥5,285.9 billion, up ¥138.0 billion from March 2024, driven by property, plant, and equipment investments.

• Net assets rose to ¥4,573.2 billion, with a high equity ratio of 83.1%.

• Cash dividends for FY2024 are forecast at ¥106 per share, up ¥6 from the previous year.

• Cash and time deposits decreased to ¥1,593.6 billion; interest-bearing liabilities fell to ¥19.0 billion.

Outlook and guidance

• FY2024 (ending March 2025) guidance maintained: net sales ¥2,500.0 billion (+3.5%), operating income ¥735.0 billion (+4.8%), net income attributable to owners of parent ¥533.0 billion (+2.5%).

• Year-end dividend expected at ¥53 per share, annual total ¥106 per share.

• Management highlights risks from exchange rates, global economic trends, and geopolitical factors.